PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary embolism |
| Phenotype | |thrombosis |
| Sentences | 81 |
| PubMedID- 25312342 | Purpose: the purpose of this investigation was to determine the prevalence of silent pulmonary embolism (pe) in patients with deep venous thrombosis (dvt) limited to the calf veins. |
| PubMedID- 25918532 | At age 50 y, he experienced a first spontaneous deep venous thrombosis (dvt) with consecutive pulmonary embolism (pe). |
| PubMedID- 26078761 | Our case involves the development of a large proximal deep venous thrombosis (dvt) with a pulmonary embolism in a patient who had received approximately 1 year of ivig for primary lateral sclerosis (pls) and possible stiff person syndrome (sps). |
| PubMedID- 20577781 | 11 cases; ischemic stroke 9 cases; peripheral arteries 3 cases; deep vein thrombosis with or without pulmonary embolism 17 cases; thrombosis in other veins 3 cases. |
| PubMedID- 25004024 | Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. |
| PubMedID- 24349803 | His past medical history was significant for a right lower extremity deep venous thrombosis with pulmonary embolism one year prior to presentation for which he is taking coumadin. |
| PubMedID- 25782637 | The progressive overgrowth causes severe complications, such as skeletal deformities, cystic lung disease, invasive lipomas, connective tissue hyperplasia, benign and malignant tumours and deep venous thrombosis with pulmonary embolism, which can cause premature death. |
| PubMedID- 22876743 | Objective: to report a case of deep vein thrombosis (dvt) with symptomatic pulmonary embolism (pe) possibly associated with the use of coltsfoot, kava, or blue vervain. |
| PubMedID- 25487168 | Background: asymptomatic or silent pulmonary embolism (s-pe) in patients with deep vein thrombosis has been the focus of numerous publications with the objective of determining the incidence of s-pe and assessing whether its existence has any clinical or therapeutic consequences that outweigh the risks associated with the diagnostic tests performed and the increased healthcare costs. |
| PubMedID- 20435232 | Background: desirudin, a bivalent direct thrombin inhibitor (dti), is approved by the us food and drug administration for the prevention of deep vein thrombosis, which may lead to pulmonary embolism, in patients undergoing elective hip replacement surgery. |
| PubMedID- 25101903 | Certain patients are at risk for deep venous thrombosis with pulmonary embolism and may benefit from an inferior vena cava filter. |
| PubMedID- 21042454 | Deep venous thrombosis (dvt), along with pulmonary embolism (pe), constitutes a disease process known as venous thromboembolic disease (vtd). |
| PubMedID- 23378750 | Both of these agents are approved by the fda for reducing the risk of stroke and systemic embolism in patients with nonvalvular af; rivaroxaban is also indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism in patients undergoing knee or hip replacement surgery.37,38 a second factor xa inhibitor, apixaban, has recently been approved by the fda. |
| PubMedID- 23831989 | The occurrence of deep vein thrombosis with subsequent pulmonary embolism can be reduced by consistent prophylaxis. |
| PubMedID- 25485923 | Similar indications include reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation for all 3 agents, for the prevention of deep vein thrombosis that may lead to pulmonary embolism in patients undergoing hip or knee surgery for rivaroxaban and apixaban, and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. |
| PubMedID- 24657810 | Bemiparin is a low molecular weight heparin (lmwh) indicated for the acute treatment of deep vein thrombosis with or without pulmonary embolism, for the prophylaxis of venous thromboembolism in surgical and non-surgical patients and for the prevention of clotting in the extracorporeal circuit during hemodialysis. |
| PubMedID- 21886029 | Objectives: compressive ultrasonography (cus) of the lower limbs is the first choice for identifying deep venous thrombosis (dvt) in patients with symptomatic pulmonary embolism (pe). |
| PubMedID- 26034614 | While overall complications were comparable between high- and low-readmission hospitals (16.3% vs 14.3%; p = .33), more postoperative pulmonary embolism/deep vein thrombosis complications were documented in patients treated at high-readmission hospitals (7.5% vs 4.1%; p = .01). |
| PubMedID- 26029307 | Large diverticulum of the urinary bladder: a rare cause of deep vein thrombosis with consecutive pulmonary embolism. |
| PubMedID- 24880697 | This confirms similarly positive results from the einstein-dvt study, which randomized 1,472 patients to rivaroxaban or enoxaparin plus vitamin k antagonists for the treatment of deep vein thrombosis not associated with pulmonary embolism [9]. |
| PubMedID- 21511805 | When we stratified cases on type of venous thromboembolism (deep venous thrombosis compared with pulmonary embolism) the results did not materially differ (odds ratio 1.9 (1.1 to 3.2) for deep venous thrombosis and 2.6 (1.6 to 4.2) for pulmonary embolism). |
| PubMedID- 23818798 | Three new oral anticoagulants, the direct thrombin inhibitor, dabigatran etexilate, and the factor xa inhibitors, rivaroxaban and apixaban, have been approved in the us for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; rivaroxaban is also approved for prophylaxis and treatment of deep vein thrombosis, which may lead to pulmonary embolism in patients undergoing knee or hip replacement surgery. |
| PubMedID- 21445339 | For example, the approved drug arixtra is a synthetic and specific inhibitor of activated factor x (xa) indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism. |
| PubMedID- 20583357 | Last year i had a deep-vein thrombosis with a small pulmonary embolism, apparently precipitated by flying across the country without getting up and walking around. |
| PubMedID- 22865417 | Anticoagulation therapy for postoperative deep vein thrombosis coupled with pulmonary embolism: a potential trigger for delayed popliteal artery injury presentation after total knee arthroplasty. |
| PubMedID- 20131193 | A case of a patient with surgically treated progressive thromboembolic pulmonary hypertension in the course of recurrent pulmonary embolism resulting from deep vein thrombosis is presented. |
| PubMedID- 21599786 | Renal vein thrombosis with pulmonary embolism: first manifestation of lupus nephritis. |
| PubMedID- 22288087 | Deep venous thrombosis with concomitant pulmonary embolism occurred in 4 of 35 patients (11.4%), with 1 of these 4 patients having only upper extremity dvt. |
| PubMedID- 23599580 | [4] suggested that surgery should be considered owing to the risk of thrombosis leading to pulmonary embolism and rupture. |
| PubMedID- 20862579 | Danaparoid sodium (the active pharmaceutical ingredient in orgaran; merck sharp and dohme) is a biopolymeric non-heparin drug used as anticoagulant and antithrombotic agent approved for the prophylaxis of post-operative deep-vein thrombosis, which may lead to pulmonary embolism in patients undergoing, e.g., elective hip replacement surgery. |
| PubMedID- 20110556 | Rationale: concomitant deep vein thrombosis (dvt) in patients with acute pulmonary embolism (pe) has an uncertain prognostic significance. |
Page: 1 2